Simultaneous melanomas in the setting of multiple primary melanomas.

IF 1.5 4区 医学 Q3 DERMATOLOGY Melanoma Research Pub Date : 2024-04-01 Epub Date: 2024-01-15 DOI:10.1097/CMR.0000000000000954
Maria Kostaki, Michaela Plaka, Aggeliki Befon, Clio Dessinioti, Katerina Kypraiou, Vasiliki Chardalia, Eleftheria Christofidou, Doris Polydorou, Alexandros Stratigos
{"title":"Simultaneous melanomas in the setting of multiple primary melanomas.","authors":"Maria Kostaki, Michaela Plaka, Aggeliki Befon, Clio Dessinioti, Katerina Kypraiou, Vasiliki Chardalia, Eleftheria Christofidou, Doris Polydorou, Alexandros Stratigos","doi":"10.1097/CMR.0000000000000954","DOIUrl":null,"url":null,"abstract":"<p><p>It is estimated that about 1-13% of melanoma patients will develop multiple primary melanomas. Although the occurrence of subsequent tumors has been described during the last few years, the development of simultaneous melanomas has not yet been extensively studied. We reviewed our registries to identify patients with multiple primary melanomas. We studied epidemiological, clinical, and histological characteristics of patients who were diagnosed with simultaneous melanomas and compared them with those of patients who developed non-synchronous multiple primary melanomas. As simultaneous were defined subsequent melanomas that were diagnosed either at the same visit or within a time-period of maximum of 1 month. Between 2000 and 2020, 2500 patients were diagnosed with melanoma at Andreas Syggros Hospital. 86 (3.4%) patients presented multiple primary melanomas and among them, 35 (40.7%) developed simultaneous melanomas. Patients with simultaneous melanomas developed more frequently more than 2 tumors. First tumors of patients with non-synchronous melanomas were significantly thicker than second tumors while those of patients with simultaneous melanomas did not differ significantly. Slight differences in the tumor localization, staging and histologic type were observed between the two groups. However significant differences were ascertained between first and second tumors in both groups. Simultaneous melanomas occupy an important proportion of multiple primary melanomas, affecting a non-negligible number of patients. Slight differences between simultaneous and non-synchronous multiple primary melanomas seem to define a distinct subcategory of multiple primary melanomas.</p>","PeriodicalId":18550,"journal":{"name":"Melanoma Research","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Melanoma Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/CMR.0000000000000954","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/15 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

It is estimated that about 1-13% of melanoma patients will develop multiple primary melanomas. Although the occurrence of subsequent tumors has been described during the last few years, the development of simultaneous melanomas has not yet been extensively studied. We reviewed our registries to identify patients with multiple primary melanomas. We studied epidemiological, clinical, and histological characteristics of patients who were diagnosed with simultaneous melanomas and compared them with those of patients who developed non-synchronous multiple primary melanomas. As simultaneous were defined subsequent melanomas that were diagnosed either at the same visit or within a time-period of maximum of 1 month. Between 2000 and 2020, 2500 patients were diagnosed with melanoma at Andreas Syggros Hospital. 86 (3.4%) patients presented multiple primary melanomas and among them, 35 (40.7%) developed simultaneous melanomas. Patients with simultaneous melanomas developed more frequently more than 2 tumors. First tumors of patients with non-synchronous melanomas were significantly thicker than second tumors while those of patients with simultaneous melanomas did not differ significantly. Slight differences in the tumor localization, staging and histologic type were observed between the two groups. However significant differences were ascertained between first and second tumors in both groups. Simultaneous melanomas occupy an important proportion of multiple primary melanomas, affecting a non-negligible number of patients. Slight differences between simultaneous and non-synchronous multiple primary melanomas seem to define a distinct subcategory of multiple primary melanomas.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
多发性原发性黑色素瘤中的同期黑色素瘤。
据估计,约有 1-13% 的黑色素瘤患者会罹患多发性原发性黑色素瘤。虽然在过去几年中已经对后续肿瘤的发生进行了描述,但尚未对同时发生黑色素瘤的情况进行广泛研究。我们查阅了我们的登记资料,以确定有多个原发性黑色素瘤的患者。我们研究了确诊为同期黑色素瘤患者的流行病学、临床和组织学特征,并与非同期多发性原发性黑色素瘤患者的特征进行了比较。同时黑色素瘤是指在同一次就诊或最长 1 个月的时间内确诊的后续黑色素瘤。2000 年至 2020 年间,安德烈亚斯-西格罗斯医院共诊断出 2500 名黑色素瘤患者。86名患者(3.4%)患有多发性原发性黑色素瘤,其中35名患者(40.7%)同时患有黑色素瘤。同时罹患黑色素瘤的患者往往同时罹患两个以上的肿瘤。非同步黑色素瘤患者的第一个肿瘤明显比第二个肿瘤厚,而同步黑色素瘤患者的肿瘤则没有明显差异。两组患者的肿瘤定位、分期和组织学类型略有不同。不过,两组患者的第一和第二肿瘤之间存在明显差异。同时发生的黑色素瘤在多发性原发性黑色素瘤中占有重要比例,患者人数不可忽视。同时性和非同步性多发性原发性黑色素瘤之间的细微差别似乎定义了多发性原发性黑色素瘤的一个独特亚类。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Melanoma Research
Melanoma Research 医学-皮肤病学
CiteScore
3.40
自引率
4.50%
发文量
139
审稿时长
6-12 weeks
期刊介绍: ​​​​​​Melanoma Research is a well established international forum for the dissemination of new findings relating to melanoma. The aim of the Journal is to promote the level of informational exchange between those engaged in the field. Melanoma Research aims to encourage an informed and balanced view of experimental and clinical research and extend and stimulate communication and exchange of knowledge between investigators with differing areas of expertise. This will foster the development of translational research. The reporting of new clinical results and the effect and toxicity of new therapeutic agents and immunotherapy will be given emphasis by rapid publication of Short Communications. ​Thus, Melanoma Research seeks to present a coherent and up-to-date account of all aspects of investigations pertinent to melanoma. Consequently the scope of the Journal is broad, embracing the entire range of studies from fundamental and applied research in such subject areas as genetics, molecular biology, biochemistry, cell biology, photobiology, pathology, immunology, and advances in clinical oncology influencing the prevention, diagnosis and treatment of melanoma.
期刊最新文献
Head and neck melanoma: the eyelid region has a better prognosis and easier management. A retrospective survey and systematic review. Causal relationship between sex hormones and cutaneous melanoma: a two-sample Mendelian randomized study. Exploring the clinical significance of specific immune-related adverse events in melanoma patients undergoing immune checkpoint inhibitor therapy. Interfering with aggregated α-synuclein in advanced melanoma leads to a major upregulation of MHC class II proteins. Efficacy of axitinib in a US cohort of patients with programmed cell death protein 1-resistant mucosal melanoma.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1